Idorsia Pharmaceutical saw the highest growth of 88% in patent filings in November and 299% in grants in December in Q4 2023. Compared to Q3 2023, Q4 2023 saw an increase in patent filings by 63% and grants by 99%. GlobalData’s DataBook provides a comprehensive analysis of Idorsia Pharmaceutical‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Idorsia Pharmaceutical has been focused on protecting inventions in United States(US) with six publications in Q4 2023
The United States(US) Patent Office dominates the patent filings and grants with nearly 13% filings and 30% grants. The South Korea(KR), United States(US), European Patent Office(EPO), and Israel(IL) patent Office are among the top ten patent offices where Idorsia Pharmaceutical is filings its patents. Among the top granted patent authorities, Idorsia Pharmaceutical has 40% of its grants in Australia(AU), 30% in United States(US) and 10% in European Patent Office(EPO).
Patents related to addiction and rare diseases lead Idorsia Pharmaceutical's portfolio
See Also:
Idorsia Pharmaceutical has the highest number of patents in addiction followed by, rare diseases. For addiction, nearly 100% of patents were filed and no patents were granted in Q4 2023.
Hypertension related patents lead Idorsia Pharmaceutical portfolio followed by asthma, and prostate cancer
Idorsia Pharmaceutical has highest number of patents in hypertension followed by asthma, prostate cancer, melanoma, and resistant hypertension. For hypertension, nearly 5% of patents were filed and 2% of patents were granted in Q4 2023.
For comprehensive analysis of Idorsia Pharmaceutical's filings and grants, buy the databook here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
